Cargando…
Computationally predicting clinical drug combination efficacy with cancer cell line screens and independent drug action
Evidence has recently emerged that many clinical cancer drug combinations may derive their efficacy from independent drug action (IDA), where patients only receive benefit from the single most effective drug in a drug combination. Here we present IDACombo, an IDA based method to predict the efficacy...
Autores principales: | Ling, Alexander, Huang, R. Stephanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673995/ https://www.ncbi.nlm.nih.gov/pubmed/33203866 http://dx.doi.org/10.1038/s41467-020-19563-6 |
Ejemplares similares
-
Independent Drug Action in Combination Therapy: Implications for Precision Oncology
por: Plana, Deborah, et al.
Publicado: (2022) -
Domain-invariant features for mechanism of action prediction in a multi-cell-line drug screen
por: Boyd, Joseph C, et al.
Publicado: (2020) -
Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen
por: Menden, Michael P., et al.
Publicado: (2019) -
Exploring the Correlation between the Cognitive Benefits of Drug Combinations in a Clinical Database and the Efficacies of the Same Drug Combinations Predicted from a Computational Model
por: Anastasio, Thomas J.
Publicado: (2019) -
Iterative sure independent ranking and screening for drug response prediction
por: An, Biao, et al.
Publicado: (2020)